Statins: Multiple Mechanisms of Action in the Ischemic Brain
- 29 June 2007
- journal article
- review article
- Published by SAGE Publications in The Neuroscientist
- Vol. 13 (3), 208-213
- https://doi.org/10.1177/1073858406297121
Abstract
Although substantial epidemiological studies have failed to find a correlation between cholesterol levels and stroke, clinical trials have shown that HMG-CoA reductase inhibitors (or statins, the most potent hypocholesterolemic drugs available) greatly reduce the incidence of stroke. These clinical observations have opened the way to a number of studies of the non—cholesterol-dependent (or pleiotropic) effects in animal models of stroke, indicating that the neuroprotection is attributable to multiple activities. One of the main protective mechanisms elicited by statin administration is the increase in nitric oxide bioavailability that regulates cerebral perfusion and improves endothelial function, but others include antioxidant properties, the inhibition of inflammatory responses, immunomodulatory actions, the regulation of progenitor cells, and the stabilization of atherosclerotic plaques. Many of these effects are due to the inhibited synthesis of isoprenoid intermediates, which serve as lipid attachments for a variety of intracellular signaling molecules. This article describes the mechanisms involved in the neuroprotective effects of statins. NEUROSCIENTIST 13(3):208—213, 2007.Keywords
This publication has 38 references indexed in Scilit:
- Inflammation, Atherosclerosis, and StrokeThe Neurologist, 2006
- Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia–ischemia in the newborn ratNeurobiology of Disease, 2006
- Statins and StrokeJournal of Cerebral Blood Flow & Metabolism, 2005
- Protective Effects of Statins Involving Both eNOS and tPA in Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2005
- Mitochondria and Neuronal Death/Survival Signaling Pathways in Cerebral IschemiaNeurochemical Research, 2004
- Prophylactic but Not Delayed Administration of Simvastatin Protects Against Long-Lasting Cognitive and Morphological Consequences of Neonatal Hypoxic-Ischemic Brain Injury, Reduces Interleukin-1β and Tumor Necrosis Factor-α mRNA Induction, and Does Not Affect Endothelial Nitric Oxide Synthase ExpressionStroke, 2003
- HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathwayJCI Insight, 2001
- Role of IL-1α and IL-1β in Ischemic Brain DamageJournal of Neuroscience, 2001
- Pathobiology of ischaemic stroke: an integrated viewTrends in Neurosciences, 1999
- Inflammatory Mediators and Stroke: New Opportunities for Novel TherapeuticsJournal of Cerebral Blood Flow & Metabolism, 1999